约氏疟原虫感染不同小鼠免疫分子的应答差异

目的探讨在约氏疟原虫感染过程中不同宿主的免疫应答差异。方法以约氏疟原虫（致死型）感染DBA／2和BALB／c小鼠，计算红细胞感染率；收集感染前和感染后1、3、6、9、12、15、20d小鼠血清，并无菌取出脾脏，培养脾细胞。应用ELISA试剂盒检测小鼠血清中IFN-γ和IL-12水平，并通过Griess方法检测脾细胞培养上清中NO含量。结果DBA／2小鼠的原虫血症峰值水平明显低于BALB／c小鼠，并于感染后第20d左右自愈；BALB／c小鼠于原虫血症达到峰值水平后全部死亡；DBA／2小鼠的IFN-γ和IL-12水平于感染后1d即出现了有意义的升高并持续到第20d；BALB／c小鼠的IFN-γ和IL-12水平仅干感染后1d出现了有意义的升高；DBA／2小鼠NO的产生于感染后3d出现了有意义的升高，第6d达到峰值，而BALB／c小鼠的NO水平始终未见明显升高。结论DBA／2小鼠通过感染早期Th1细胞免疫应答的有效建立能够抑制原虫血症，IL-12是启动并维持Th1细胞免疫应答的关键性细胞因子。     

Generation and survival of midbrain dopaminergic neurons in weaver mice

Generation and survival of midbrain dopaminergic (DA) neurons were investigated using tyrosine hydroxylase (TH) immunocytochemistry combined with tritiated thymidine autoradiography at appropriate anatomical levels throughout the anteroposterior (A/P) axes of the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA). The wild-type (+/+) and homozygous weaver (wv/wv) mice used here were the offspring of pregnant dams injected with the radioactive precursor when the mesencephalic neurons were being produced (gestational days 11-15). Data reveal that, at postnatal day 90, depletion of TH-stained cells in the wv/wv presented an A/P pattern of increasing severity and, therefore, the DA cells located in posterior parts of the SNc or the VTA appear to be more vulnerable than the settled anterior neurons. When the time of neuron origin is inferred for each level of these cell groups, it is found that the neurogenesis span is similar for both experimental groups, although significant deficits in the frequency of wv/wv late-generated neurons were observed in any level considered. On the other hand, it has been found that TH-positive neurons were settled along the extent of the SNc and the VTA following precise and differential neurogenetic gradients. Thus, the acute rostrocaudal increase in the proportion of late-generated neurons detected in both+/+DA-cell groups is disturbed in the weaver homozygotes due to the indicated A/P depletion.     

综合疗法治疗儿童单纯性肥胖症31例

目的探讨综合疗法治疗儿童肥胖症的疗效。方法对31例儿童肥胖症患者进行综合治疗，包括大黄膏身体各部位按摩，用内分泌治疗仪或用远红外线灯照射全身穴位，女患儿加用太空衣治疗，然后采用电脑减肥治疗仪在全身各部位进行治疗。同时制定饮食处方和运动处方并进行行为指导。结果治疗组体重减少5～10k，有效率93．5％；对照组体重减少2～4kg，有效率46．7％。同时腰围明显减小。结论综合疗法治疗儿童肥胖症是很有效的。且无任何不良反应。     

局部注射VEGF对大鼠正畸牙齿移动的影响

目的：观察局部注射重组鼠的血管内皮生长因子(rrVEGF)对大鼠正畸牙齿移动的影响，探讨VEGF在正畸牙齿移动中的作用机制。方法：45只雄性SD大鼠，牵引其上颌第一磨牙近中移动，实验中分别将rrVEGF及生理盐水注射入实验组及对照组大鼠右侧上颌第一磨牙腭侧的骨粘膜下，于实验前3天开始注射，每3天一次。分别在加力l、3、7、14、2l天后记录上颌第一磨牙移动距离。然后将各组动物处死，用HE染色观察牙周组织变化情况并采用免疫组织化学方法对组织中表达的VEGF进行分析。结果：实验组大鼠压力侧破骨细胞教和成骨细胞数在实验全过程中均多于对照组，而且，实验组大鼠牙齿移动距离明显大于对照组。结论：进一步证实VEGF作为旁分泌因子，参与了牙齿移动过程中的牙周组织改建，内源性VEGF和注射VEGF都使牙齿移动量显著增加。因此，VEGF在正畸牙齿移动的机制中具有重要意义。     

聚合酶链反应检测实验动物弓形虫核酸的研究

建立弓形虫动物模型，常规方法提取肝、脾、肾、肺等组织DNA，应用聚合酶链反应（PCR）扩增，产物经电泳检测显示199bp的弓形虫特异带谱。并以γ－32p标记克隆的弓形虫特异DNA片段为探针，对扩增产物行Southern印迹分析，结果上述4种标本均出现阳性杂交带，进一步证实扩增条带是弓形虫特异DNA顺序。同时用酶标法检测显示鼠血清弓形虫抗体IgG；阳性。组织病理学检查结果，肝组织损伤较严重，肝细胞肿大，肝窦消失，脾、肾、肺组织可见轻微的病理改变。另外本文介绍一种简单PCR方法[1]，取鼠尾静脉血2μl直接进行扩增，结果与酚-氯仿法提取的DNA扩增结果一致。     

附子理中丸方药的药物动力学研究

附子理中丸是中医治疗脾胃虚寒、脘腹冷痛、呕吐泄泻、手足不温的常用成药。本文通过小白鼠急性死亡实验,测得ip LD_(50)=42.4870g/kg;运用药物累积法对该复方方药进行了药物动力学研究。结果表明:附子理中丸在小鼠体内按一级动力学消除,呈二房室开放式模型分布。测得其t_(1/2)α=0.1922h,t_(1/2)β=11.2888h等动力学参数。阐明了该药的体内动态过程,为评价该药的内在质量及临床安全合理应用提供了参考依据。     

雷公藤多甙对小鼠Ⅳ型超敏反应影响的研究

采用动物实验，选择Ⅳ型超敏反应局部渗出性改变、Ｔ细胞增殖能力的强弱和病理形态学观察等指标，研究了雷公藤多甙（ＴｒｉｐｔｅｒｙｇｉｕｍＷｉｌｆｏｒｄｉｉＰｏｌｙｇｌｙｃｏ－Ｓｏｄｉｕｍ，ＴＷＰ）对ＯＴ诱导的Ⅳ型超敏反应小鼠模型的影响。结果表明，经ＴＷＰ灌胃９～１５天的小鼠，发敏的局部渗出性改变明显降低，与未给药的模型组相比，Ｐ＜０．０５，病理形态学观察结果亦与之相符。ＴＷＰ的这种作用可能与已报道的其多种免疫抑制效应有关。     

Induction of Experimental Antiphospholipid Antibody Syndrome in PL/J Mice Following Immunization With β2GPI

PROBLEM: Immunization with β₂-glycoprotein I (β₂GPI) induces antiphospholipid antibodies (aPL) in normal mice and rabbits. Recently we reported early onset of autoimmunity in MRL/++ mice following immunization with β₂GPI. There is a close association between aPL with thrombosis, recurrent fetal loss, and intrauterine growth retardation. In this study we evaluated the effect of β₂GPI-induced aPL on pregnancy outcomes in an inbred strain of mice (PL/J). METHOD: Three groups of seven-week-old female PL/J mice (12 per group) were studied. Group A was immunized with β₂GPI and group B with ovalbumin; group C was not immunized. After two booster injections, the mice were tested for aPL, anti-DNA by ELISA, and for ANA by indirect immunofluorescence. Platelet count and pregnancy outcomes were studied at the age of 14 weeks. RESULTS: The aPL and anti-DNA levels were higher at 12 and 14 weeks in group A; the optical densities (OD) were 1.72±0.6 and 0.699±0.25 for group A, 0.091 ±0.040 and 0.230±0.47 for group B, and 0.0435±0.003 and 0.119±0.026 for group C (comparing group A with groups B and C combined, P<0.001). ANA titers rose in groups A and B by age, but they were significantly higher at 14 weeks in group A. The mean titers were 1/286, 1/90, and 1/16 for A, B, and C, respectively (P<0.001). The platelet counts were not significantly different among the three groups. The litter size was significantly smaller in group A, as evidenced by the numbers of viable fetuses among the mice that became pregnant in each group: 0.75, 2.45, and 5.5 in groups A, B, and C, respectively. Seven pregnant mice in group A had complete resorption, seven pregnant mice in group B showed focal (partial) resorption areas, and only one mouse in group C had complete resorption of the embryos, as shown by histopathological studies, although the fecundity rate was similar in the three groups. CONCLUSION: Our data suggest a pathogenic role for β₂GPI-induced aPL in the development of experimental models of APS in PL/J mice.     

乌苯美司的药物动力学及对实验性肿瘤转移的治疗作用

目的：探讨乌苯美司对小鼠药物动力学及与实验性肿瘤转移治疗活性间的关系。方法：用放射免疫法测定小鼠在不同给药途径下的乌苯美司血清药物动力学及观察乌苯美司对黑色素瘤肺转移模型的治疗活性。结果：乌苯美司ｉｖ的Ｔ１２较短，初始血药浓度较高。ｉｖ和ｉｍ给药后的曲线下面积较大；ｐｏ及ｉｐ则较小。不同给药途径对实验性肿瘤转移均有治疗作用。结论：乌苯美司的血清Ｔ１２较短，其治疗活性取决于冲击和高剂量的给药方式。     

In vivo and in vitro anti-tumour response of selenium-protein polysaccharide extracted from rich selenium Agaricus blazei

In this study, the anti-tumour activity of selenium-protein polysaccharide (SPP), a water extract of the rich selenium Agaricus blazei, was tested both in vivo and in vitro. The results of in vivo experiments show that SPP at doses of 50 and 100 mg/kg inhibits proliferation of implanted Sarcoma 180 by 22 and 37.69%, respectively, and promotes lymphocyte transformation and natural killer (NK) cells activity in tumour bearing mice. During the in vitro experiment, we treated the tumour and non-tumour bearing mice with SPP, and prepared serum treated with SPP (Serum_SPP). The results show that Serum_SPP, whether from tumour or non-tumour bearing mice, significantly inhibits K562 cells proliferation and induces their apoptosis, and also significantly increases caspase-3 activity of K562 cells. However, the difference in anti-tumour activity of Serum_SPP between tumour and non-tumour bearing mice is significantly different (p<0.01). The results, according to the studies both in vivo and in vitro, imply that SPP extracted from rich selenium A. blazei can inhibit growth of implanted Sarcoma 180 and promote lymphocyte transformation and NK cells activity in vivo. Additionally, Serum_SPP can inhibit proliferation and cause apoptotic morphological changes and the fragmentation of internucleosomal DNA, and increase caspase-3 activity of K562 cells in vitro, which indicates that apoptosis of K562 cells induced by Serum_SPP may be related to up-regulation of caspase-3.